Furthermore, quercetin can reverse docetaxel-resistance in vitro and in vivo through the AR and PI3K/Akt signaling pathways, supporting its clinical use in docetaxel-resistant PCa [596]. Here, AKT1 is linked to posterior cortical atrophy.